동국제약

086450KOSDAQView the 제약 sectorTheme Bio & healthcare

25,050KRWMarket close of 10/20 (Tue)

Down -0.79%-200KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)24,650KRWDown -1.60%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
25,500
High
26,250
Low
24,400
Day range
Day range low 24,400 high 26,250, open 25,500, close 25,050, previous close 25,250
Volume
64×10K shares
16.2B KRW 1.14× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 16,420 to 29,900 won, 64% up from the low

64% of the way up from the lowest close in 1 year (252 sessions) · -16.2% from the high

Usual range

Nothing unusual in the 6 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Daily moveusual range-0.79%-0.79%, 0.3× the usual (20-session average ±2.44%)
    That day -0.79% · usual ±2.44% · large-move threshold ±4.9%
  • Trading valueusual range1.1×16.2B KRW, 1.1× the 20-session average
    1.14× the 20-session average · check threshold 3×
  • Earningsusual range102.5B KRWOperating income over the last four quarters 102.5B KRWOperating income, 8 quarters

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional+9.8B KRWusual range
  • Data date10/20 (Tue)Market close
See the full check report

Same sector · 제약

Down -1.68%

· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
셀트리온Close over the last 20 sessions +11.4%Down -0.40%139.2B KRW
삼성바이오로직스Close over the last 20 sessions -1.3%Down -2.52%129.9B KRW
삼익제약Close over the last 20 sessions -20.4%Up +2.77%76.0B KRW
녹십자엠에스Close over the last 20 sessions +30.5%Up +6.67%55.6B KRW
유한양행Close over the last 20 sessions +11.5%Down -1.37%41.6B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 26 days
  • Next data 10/22 (Thu) after 08:50

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.